Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Companion Animals

Set Alert for Companion Animals

Carus Animal Health aims to fill animal welfare innovation gaps

Formed in 2017, Carus Animal Health is a UK-based business backed by Japan's largest animal health firm Kyoritsu Seiyaku. The new company has a mandate to stimulate innovation. Animal Pharm editor Joseph Harvey met Carus to explore its strategy for addressing unmet needs.

R&D Food Animals

GeneQuine osteoarthritis therapy secures positive efficacy data

German firm GeneQuine Therapeutics has gained positive efficacy data for the gene therapy approach developed by the firm and Baylor College of Medicine.

R&D Companion Animals

Aratana begins developing AT-019 to build on EP4 base

Aratana Therapeutics is progressing R&D work on a candidate that targets the prostaglandin EP4 receptor.

Aratana Therapeutics R&D

Animal Pharm Podcast #13: Anizome sheds light on the burgeoning animal microbiome opportunity

In this latest Animal Pharm podcast, editor Joseph Harvey finds out how addressing the microbiome is changing the way the animal health industry approaches R&D. To understand the potential of microbiome products, he spoke to Oliver Hardcastle – the chief executive of new firm Anizome.

Feed & Additives Companion Animals

Bayer takes a closer look at pet allergy sector with NeuroCycle pact

Bayer Animal Health and NeuroCycle Therapeutics (NCT) have signed a global license agreement to bring a companion animal allergy treatment to market.

R&D Bayer Animal Health

Report underlines shifting trends of 'new school' pet ownership

Unfenced Animal Health Experts, a division of US-based JNA Advertising, has co-compiled a report, Pet Owner Paths, alongside Merck Animal Health and Kynetec with the intention of learning more about the differences between "new school" and traditional pet owners. Animal Pharm analyst Daniel Willis met Karen Padgett, president of Unfenced, to talk about the report's findings.

Research Feline

Major Japanese bank to promote pet insurance

Tokyo-based Sumitomo Mitsui Banking Corporation (SMBC) is to promote pet health insurance in a new agreement.

Japan Companion Animals

US start-up building smart collar capabilities for pet, livestock industries

Scollar is creating the first open platform smart collar, mobile app and cloud service for multiple species.

Equipment & Technology Companion Animals

Boehringer launches first EU liquid solution for hypertension in cats

Boehringer Ingelheim has launched Semintra, which is the first oral solution to deal with feline hypertension.

Boehringer Ingelheim Animal Health Pharmaceuticals

CannPal commences next phase of biotherapeutic safety study

CannPal Animal Therapeutics has commenced the next phase of a pharmacokinetic and safety study for a cannabis-derived veterinary medicine to be used in pain control in dogs.

R&D Canine

US biotech firm Torigen looking to form partnerships for personalized cancer treatment

Kansas City Animal Health Investment Forum 2018 victor Torigen Pharmaceuticals has announced its intention to form partnerships within the animal health industry.

R&D Companion Animals

Panion reaches next stage of development with positive safety studies

Panion Animal Health has successfully gained positive preliminary results from a safety study of its gene therapy treatment for dogs with epilepsy.

Canine R&D
See All